Aeluma Reports Mixed Q2 Results, Alleviates Going Concern, But Discloses Internal Control Weakness and Executive Selling Plans
ALMU has more than doubled off its 52-week low of $5.69 on elevated volume (1.9× avg).
Summary
Aeluma, Inc. reported increased revenue but continued net losses for Q2 fiscal 2026, while successfully alleviating going concern doubts due to recent capital raises. However, the company disclosed a material weakness in internal controls and revealed that its CEO/Chairman and a Director adopted Rule 10b5-1 selling plans.
Key Events · Earnings and Guidance · ALMU
-
Improved Liquidity & Alleviated Going Concern
Cash and cash equivalents surged to $38.57 million as of December 31, 2025, from $3.63 million at June 30, 2025, primarily due to $23.4 million in net proceeds from a September 2025 public offering. This capital infusion has alleviated prior substantial doubt about the company's ability to continue as a going concern.
-
Material Weakness in Internal Controls
Management concluded that disclosure controls and procedures were ineffective as of December 31, 2025, citing insufficient finance department staffing and inadequate precision/timeliness of review controls. Remediation efforts, including hiring a new CFO, are underway.
-
Mixed Financial Performance
Revenue increased 27% to $2.66 million for the six months ended December 31, 2025, compared to the prior year. However, net loss for the same period was $(3.35) million, and total operating expenses significantly increased by 161% to $6.35 million, driven by material purchases and higher compensation costs.
-
Executive Selling Plans Adopted
Steven DenBaars (Director) adopted a Rule 10b5-1 plan on November 20, 2025, to sell up to 100,000 shares. Jonathan Klamkin (President, CEO, and Chairman) adopted a similar plan on December 3, 2025, to sell up to 150,000 shares. These plans follow a trend of recent insider distribution.
Analysis · ALMU · Manufacturing
Aeluma's latest 10-Q presents a mixed financial picture. While the company successfully raised substantial capital through public offerings, significantly boosting its cash reserves and alleviating prior going concern doubts, operational profitability remains a challenge with increased net losses and surging operating expenses. The disclosure of ineffective disclosure controls and procedures is a significant negative, indicating potential risks in financial reporting reliability, despite ongoing remediation efforts. Furthermore, the adoption of Rule 10b5-1 selling plans by the CEO/Chairman and a Director, following a trend of recent insider selling and a large resale registration, could be perceived negatively by investors, suggesting a lack of conviction at a critical juncture for the company.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALMU was trading at $16.50 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $299.8M. The 52-week trading range was $5.69 to $25.88. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.